• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性ST段抬高型心肌梗死患者的冠状动脉疾病家族史与不良临床结局

Family history of coronary artery disease and adverse clinical outcomes in patients suffering from acute ST-segment elevation myocardial infarction.

作者信息

Preisler Yoav, Ziv-Baran Tomer, Chorin Ehud, Margolis Gilad, Khoury Shafik, Shacham Yacov

机构信息

Sackler Faculty of Medicine.

Department of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine.

出版信息

Coron Artery Dis. 2018 Dec;29(8):657-662. doi: 10.1097/MCA.0000000000000667.

DOI:10.1097/MCA.0000000000000667
PMID:30308587
Abstract

BACKGROUND

A positive family history (FHx+) of coronary artery disease (CAD) is a well-known risk factor for the development of coronary pathology in first-degree relatives. We sought to evaluate the association between FHx+ of CAD and clinical outcomes in patients presenting with a first ST-elevation myocardial infarction (STEMI).

PATIENTS AND METHODS

A historical cohort study of all patients with a first STEMI, who were admitted to cardiac ICU between 2007 and 2016, was carried out. Univariate and multivariate analyses were carried out to compare patients with or without a FHx+ of CAD. In further analysis, propensity score matching was used to reduce differences in baseline characteristics.

RESULTS

The study included 1785 patients, 365 (20%) of whom had FHx+ of CAD. FHx+ was associated with decreased in-hospital major adverse events and long-term mortality rates (hazard ratio=0.208, 95% confidence interval: 0.051-0.857; P=0.03). After propensity score matching, patients with FHx+ had decreased long-term mortality rates (hazard ratio=0.105, 95% confidence interval: 0.033-0.33; P<0.001).

CONCLUSION

In this large cohort of patients with STEMI, FHx+ was associated with better short-term and long-term outcomes. Understanding the rule of FHx in patients with STEMI is important to evaluate the prognosis and may help to construct a prediction model for patients admitted to cardiac ICU.

摘要

背景

冠心病(CAD)的阳性家族史(FHx+)是一级亲属发生冠状动脉病变的一个众所周知的危险因素。我们试图评估CAD的FHx+与首次ST段抬高型心肌梗死(STEMI)患者临床结局之间的关联。

患者与方法

对2007年至2016年间入住心脏重症监护病房的所有首次发生STEMI的患者进行了一项历史性队列研究。进行单因素和多因素分析以比较有无CAD的FHx+的患者。在进一步分析中,采用倾向评分匹配来减少基线特征的差异。

结果

该研究纳入了1785例患者,其中365例(20%)有CAD的FHx+。FHx+与住院期间主要不良事件减少和长期死亡率降低相关(风险比=0.208,95%置信区间:0.051-0.857;P=0.03)。倾向评分匹配后,有FHx+的患者长期死亡率降低(风险比=0.105,95%置信区间:0.033-0.33;P<0.001)。

结论

在这个大型STEMI患者队列中,FHx+与较好的短期和长期结局相关。了解FHx在STEMI患者中的规律对于评估预后很重要,并且可能有助于构建入住心脏重症监护病房患者的预测模型。

相似文献

1
Family history of coronary artery disease and adverse clinical outcomes in patients suffering from acute ST-segment elevation myocardial infarction.急性ST段抬高型心肌梗死患者的冠状动脉疾病家族史与不良临床结局
Coron Artery Dis. 2018 Dec;29(8):657-662. doi: 10.1097/MCA.0000000000000667.
2
Relation Between Family History of Premature Coronary Artery Disease and the Risk of Death in Patients With Coronary Artery Disease.早发冠状动脉疾病家族史与冠状动脉疾病患者死亡风险之间的关系
Am J Cardiol. 2016 Feb 1;117(3):353-8. doi: 10.1016/j.amjcard.2015.11.008. Epub 2015 Nov 18.
3
Association Between Family History, a Genetic Risk Score, and Severity of Coronary Artery Disease in Patients With Premature Acute Coronary Syndromes.早发急性冠脉综合征患者的家族史、遗传风险评分与冠状动脉疾病严重程度之间的关联
Arterioscler Thromb Vasc Biol. 2016 Jun;36(6):1286-92. doi: 10.1161/ATVBAHA.115.306944. Epub 2016 Apr 21.
4
Correlation of Admission Heart Rate With Angiographic and Clinical Outcomes in Patients With Right Coronary Artery ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: HORIZONS-AMI (The Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) Trial.接受直接经皮冠状动脉介入治疗的右冠状动脉ST段抬高型心肌梗死患者入院心率与血管造影及临床结局的相关性:HORIZONS-AMI(急性心肌梗死血管重建和支架置入的协调结局)试验
J Am Heart Assoc. 2017 Jul 19;6(7):e006181. doi: 10.1161/JAHA.117.006181.
5
Differences in Short- and Long-Term Outcomes Among Older Patients With ST-Elevation Versus Non-ST-Elevation Myocardial Infarction With Angiographically Proven Coronary Artery Disease.经血管造影证实患有冠状动脉疾病的老年ST段抬高型与非ST段抬高型心肌梗死患者的短期和长期预后差异。
Circ Cardiovasc Qual Outcomes. 2016 Sep;9(5):513-22. doi: 10.1161/CIRCOUTCOMES.115.002312. Epub 2016 Sep 6.
6
Twelve-month clinical outcomes of acute non-ST versus ST-segment elevation myocardial infarction patients with reduced preprocedural thrombolysis in myocardial infarction flow undergoing percutaneous coronary intervention.急性非ST段抬高型与ST段抬高型心肌梗死患者在经皮冠状动脉介入治疗前心肌梗死血流溶栓降低的情况下的12个月临床结局。
Coron Artery Dis. 2018 Aug;29(5):416-422. doi: 10.1097/MCA.0000000000000632.
7
First-degree relatives with similar phenotypic characterisation of acute myocardial infarction: a case report and review of the literature.具有相似急性心肌梗死表型特征的一级亲属:一例病例报告及文献综述
BMC Cardiovasc Disord. 2019 Dec 27;19(1):314. doi: 10.1186/s12872-019-01303-4.
8
Immediate multivessel revascularization may increase cardiac death and myocardial infarction in patients with ST-elevation myocardial infarction and multivessel coronary artery disease: data analysis from real world practice.直接多支血管血运重建术可能会增加ST段抬高型心肌梗死合并多支冠状动脉疾病患者的心源性死亡和心肌梗死风险:来自真实临床实践的数据分析
Korean J Intern Med. 2016 May;31(3):488-500. doi: 10.3904/kjim.2014.119. Epub 2016 Apr 6.
9
Culprit Vessel Versus Multivessel Versus In-Hospital Staged Intervention for Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: Stratified Analyses in High-Risk Patient Groups and Anatomic Subsets of Nonculprit Disease.罪犯血管与多血管与住院分期介入治疗 ST 段抬高型心肌梗死和多血管病变患者:高危患者群体和非罪犯病变的解剖亚组的分层分析。
JACC Cardiovasc Interv. 2017 Jan 9;10(1):11-23. doi: 10.1016/j.jcin.2016.10.024.
10
Pharmacoinvasive Strategy Versus Primary Percutaneous Coronary Intervention in Patients With ST-Segment-Elevation Myocardial Infarction: A Propensity Score-Matched Analysis.ST段抬高型心肌梗死患者药物介入策略与直接经皮冠状动脉介入治疗的倾向评分匹配分析
Circ Cardiovasc Interv. 2016 Sep;9(9). doi: 10.1161/CIRCINTERVENTIONS.115.003508.

引用本文的文献

1
Joint Association of Lipoprotein(a) and a Family History of Coronary Artery Disease with the Cardiovascular Outcomes in Patients with Chronic Coronary Syndrome.载脂蛋白(a)与冠状动脉疾病家族史与慢性冠状动脉综合征患者心血管结局的联合关联。
J Atheroscler Thromb. 2024 Sep 1;31(9):1319-1332. doi: 10.5551/jat.64693. Epub 2024 Apr 13.
2
A Systematic Review on the Risk Modulators of Myocardial Infarction in the "Young"-Implications of Lipoprotein (a).脂蛋白(a)与“年轻”人群心肌梗死风险因素的系统评价
Int J Mol Sci. 2023 Mar 21;24(6):5927. doi: 10.3390/ijms24065927.
3
Prognostic significance of positive family history in outcomes after coronary artery bypass grafting: Do we need to update our assumptions?
阳性家族史对冠状动脉旁路移植术后结局的预后意义:我们是否需要更新我们的假设?
J Cardiothorac Surg. 2022 Apr 27;17(1):84. doi: 10.1186/s13019-022-01836-4.
4
Sex and age difference in risk factor distribution, trend, and long-term outcome of patients undergoing isolated coronary artery bypass graft surgery.性别和年龄对行单纯冠状动脉旁路移植术患者的危险因素分布、趋势和长期预后的影响。
BMC Cardiovasc Disord. 2021 Sep 23;21(1):460. doi: 10.1186/s12872-021-02273-2.